GPT Healthcare Intrinsic Value
GPT Healthcare intrinsic value. GPT Healthcare (GPTHEALTH) median intrinsic value is ₹71.43 from 3 valuation models (range ₹30–₹112), vs current price ₹149.56 — -52.2% downside (Trading Above Calculated Value), margin of safety -100.0%. Compare with GPTHEALTH fair value estimate to assess whether the stock is under or overvalued.
GPTHEALTH Valuation Methods Summary — DCF, Graham Number & P/E
GPT Healthcare intrinsic value across 3 models vs current price ₹149.56 — upside/downside and value range per method. For current market price and key ratios, visit GPTHEALTH stock price BSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹29.91 | ₹26.92 - ₹32.90 | -80.0% | Book Value/Share: ₹19.75, P/B: 1.0x |
| Simple DCF (5Y) | dcf | ₹112.06 | ₹89.65 - ₹134.47 | -25.1% | CF Growth: 15.0%, Discount: 15% |
| Dividend Yield Method | dividend | ₹71.43 | ₹64.29 - ₹78.57 | -52.2% | DPS: ₹2.50, Target Yield: 3.5% |
GPTHEALTH Intrinsic Value vs Market Price — All Valuation Models
GPT Healthcare fair value range ₹30–₹112 vs current market price ₹149.56 across 3 valuation models. Read GPTHEALTH dividend payout details for the complete payout history and dividend yield track record.
GPTHEALTH Intrinsic Value Analysis — Undervalued or Overvalued?
GPT Healthcare median intrinsic value ₹71.43, current price ₹149.56 — Trading Above Calculated Value by 52.2%, margin of safety -100.0%.
What is the intrinsic value of GPTHEALTH?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of GPT Healthcare (GPTHEALTH) is ₹71.43 (median value). With the current market price of ₹149.56, this represents a -52.2% variance from our estimated fair value.
The valuation range spans from ₹29.91 to ₹112.06, indicating ₹29.91 - ₹112.06.
Is GPTHEALTH undervalued or overvalued?
Based on our multi-method analysis, GPT Healthcare (GPTHEALTH) appears to be trading above calculated value by approximately 52.2%.
GPTHEALTH Financial Health — Key Ratios vs Industry Benchmarks
GPT Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.89 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
GPTHEALTH Cash Flow Quality — Operating & Free Cash Flow
GPT Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2022 | ₹66 Cr | ₹64 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹43 Cr | ₹35 Cr | Positive Free Cash Flow | 8/10 |
| March 2020 | ₹42 Cr | ₹15 Cr | Positive Free Cash Flow | 7/10 |